| __timestamp | Lantheus Holdings, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 504755000 |
| Thursday, January 1, 2015 | 78634000 | 838526000 |
| Friday, January 1, 2016 | 75374000 | 1177697000 |
| Sunday, January 1, 2017 | 92157000 | 1320433000 |
| Monday, January 1, 2018 | 93326000 | 1556200000 |
| Tuesday, January 1, 2019 | 103132000 | 1834800000 |
| Wednesday, January 1, 2020 | 110171000 | 1346000000 |
| Friday, January 1, 2021 | 218817000 | 1824900000 |
| Saturday, January 1, 2022 | 233827000 | 2115900000 |
| Sunday, January 1, 2023 | 267194000 | 2631300000 |
| Monday, January 1, 2024 | 2954400000 |
Data in motion
In the competitive world of biotechnology, managing expenses is crucial for sustained growth. Over the past decade, Regeneron Pharmaceuticals, Inc. and Lantheus Holdings, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Regeneron's SG&A expenses surged by over 420%, peaking at approximately $2.63 billion in 2023. This reflects their aggressive expansion and investment in innovation. In contrast, Lantheus Holdings, Inc. experienced a more modest increase of around 270%, reaching $267 million in 2023. This indicates a more conservative approach, focusing on steady growth and operational efficiency. The data highlights the strategic differences between these two industry leaders, offering insights into their financial management and market positioning. As the biotech sector continues to evolve, understanding these trends is essential for investors and industry analysts alike.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: SG&A Expense Trends
Regeneron Pharmaceuticals, Inc. vs Ascendis Pharma A/S: SG&A Expense Trends
Regeneron Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited Trends and Insights
Regeneron Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for Summit Therapeutics Inc. and Lantheus Holdings, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Amicus Therapeutics, Inc.
Lantheus Holdings, Inc. vs Vericel Corporation: SG&A Expense Trends
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.